Camrelizumab Plus Sorafenib Versus Sorafenib Monotherapy for Advanced Hepatocellular Carcinoma: A Retrospective Analysis

BACKGROUND: Hepatocellular carcinoma (HCC) is a highly aggressive malignancy with poor prognosis. Immunotherapy has gained great interest for various solid tumors due to its promising clinical efficacy. Targeted therapy also plays a crucial role in anticancer treatment. However, studies on the combi...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Qinqin, You, Nan, Li, Jing, Wu, Ke, Peng, Xuehui, Wang, Zheng, Wang, Liang, Zhu, Yinan, Zheng, Lu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8560727/
https://www.ncbi.nlm.nih.gov/pubmed/34737945
http://dx.doi.org/10.3389/fonc.2021.694409

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8560727/
https://www.ncbi.nlm.nih.gov/pubmed/34737945
http://dx.doi.org/10.3389/fonc.2021.694409

Ejemplares similares